446 participants
A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-31
- Start Date:
- 2025-05-06
- Completion:
- 2029-05-31
Conditions
- Recurrent or Metastatic Nasopharyngeal Carcinoma
Interventions
- DRUG
No Results Yet